Skip to main content
Andrew Heitzer, PhD, ABPP-CN
Andrew Heitzer, PhD, ABPP-CN

Andrew Heitzer, PhD, ABPP-CN

Instructor, St. Jude Faculty

  • Board Certified in Clinical Neuropsychology

Departments

Education

BS (Psychology) - Drake University, Des Moines, IA
PhD (Clinical Psychology) - Wayne State University, Detroit, MI
Pre-doctoral Internship - St. Jude Children’s Research Hospital / University of Tennessee Health Science Center, Memphis, TN
Post-doctoral Fellowship Texas Children’s Hospital / Baylor College of Medicine, Houston, TX

Research Interests

  • Neurocognitive functioning in sickle cell disease
  • Development of interventions to improve neurocognitive and academic outcomes
  • Neurocognitive factors impacting transition to adult care and treatment adherence

Selected Publications

Heitzer AM, Longoria J, Rampersaud E, Rashkin SR, Estepp JH, Okhomina VI, Wang WC, Raches D, Potter B, Steinberg MH, King AA, Kang G,Hankins JS. Fetal hemoglobin modulates neurocognitive performance in sickle cell anemia. Curr Res Transl Med 70(3), 103335, 2022. doi:10.1016/j.retram.2022.103335

Trpchevska A, Longoria J, Okhomina V, Raches D, Potter B, Kang G, Heitzer AM, Hankins JS. Adaptive Functioning in Children and Adolescents With Sickle Cell Disease. Journal of Pediatric Psychology Apr 5;jsac024, 2022. doi:10.1093/jpepsy/jsac024

Heitzer AM, Cohen DL, Okhomina VI, Trpchevska A, Potter B, Longoria J, Porter JS, Estepp JH, King A, Henley M, Kang G, Hankins JS. Neurocognitive functioning in preschool children with sickle cell disease. Pediatric Blood & Cancer 69(3):e29531, 2022. doi:10.1002/pbc.29531

Boggs, J., Freeman, M., Okhomina, V. I., Kang, G., Heitzer, A. M., & Wang, W. C. (2022). Reading intervention targeting phonemic awareness and symbol imagery in children with sickle cell disease. Pediatric Blood & Cancer, 69(3), e29561. doi:10.1002/pbc.29561

Longoria JN, Heitzer AM, Hankins JS, Trpchevska A, Porter JS. Neurocognitive risk in sickle cell disease: Utilizing neuropsychology services to manage cognitive symptoms and functional limitations. British Journal of Haematology Feb 4, 2022. doi:10.1111/bjh.18041

Champlin G, Hwang SN, Heitzer A, Ding J, Jacola L, Estepp JH, Wang W, Ataga KI, Owens CL, Newman J, King AA, Davis R, Kang G, Hankins JS. Progression of central nervous system disease from pediatric to young adulthood in sickle cell anemia. Experimental Biology and Medicine (Maywood, NJ) 246(23):2473-2479, 2021. doi:10.1177/15353702211035778

Heitzer AM, Hamilton L, Stafford C, Gossett J, Ouellette L, Trpchevska A, King AA, Kang G, Hankins JS. Academic Performance of Children With Sickle Cell Disease in the United States: A Meta-Analysis. Frontiers in Neurology 12:786065, 2021. doi:10.3389/fneur.2021.786065

Wang WC, Zou P, Hwang SN, Kang G, Ding J, Heitzer AM, Schreiber JE, Helton K, Hankins JS. Effects of hydroxyurea on brain function in children with sickle cell anemia. Pediatric Blood & Cancer 68(10):e29254, 2021. doi:10.1002/pbc.29254

Heitzer AM, Longoria J, Okhomina V, Wang WC, Raches D, Potter B, Jacola LM, PorterJ, Schreiber JE, King AA, Kang G, Hankins JS. Hydroxyurea treatment and neurocognitive functioning in sickle cell disease from school age to young adulthood. British Journal of Haematology 195(2):256-266, 2021. doi:10.1111/bjh.17687

Wang W, Freeman M, Hamilton L, Carroll Y, Kang G, Moen J, Smeltzer MP, Schreiber J, Heitzer AM, Estepp J, Aygun B. Developmental screening of three-year-old children with sickle cell disease compared to controls. British Journal of Haematology 195(4):621-628, 2021. doi:10.1111/bjh.17780

Last update: April 2022

Close